These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
63. A case of Pityriasis rosea concurrent with the novel influenza A (H1N1) infection. Mubki TF; Bin Dayel SA; Kadry R Pediatr Dermatol; 2011; 28(3):341-2. PubMed ID: 20403114 [TBL] [Abstract][Full Text] [Related]
64. [Idiopathic eruptive macular pigmentation following pityriasis rosea. Presentation of two cases (author's transl)]. Dupré A; Christol B; Albarel N; Rumeau H Ann Dermatol Venereol; 1980 May; 107(5):413-7. PubMed ID: 7224525 [TBL] [Abstract][Full Text] [Related]
65. Pityriasis rosea: an update with a critical appraisal of its possible herpesviral etiology. Drago F; Broccolo F; Rebora A J Am Acad Dermatol; 2009 Aug; 61(2):303-18. PubMed ID: 19615540 [TBL] [Abstract][Full Text] [Related]
66. Pityriasis rosea-like eruption during treatment with imatinib mesylate: description of 3 cases. Brazzelli V; Prestinari F; Roveda E; Barbagallo T; Bellani E; Vassallo C; Orlandi E; Passamonti F; Borroni G J Am Acad Dermatol; 2005 Nov; 53(5 Suppl 1):S240-3. PubMed ID: 16227099 [TBL] [Abstract][Full Text] [Related]
71. The pityriasis rosea calendar: a 7 year review of seasonal variation, age and sex distribution. Ayanlowo O; Akinkugbe A; Olumide Y Nig Q J Hosp Med; 2010; 20(1):29-31. PubMed ID: 20450028 [TBL] [Abstract][Full Text] [Related]
72. [Skin rash mimicking pityriasis rosea Gibert secondary to pristinamycin therapy]. Schmutz JL; Trechot P Ann Dermatol Venereol; 2014 Apr; 141(4):325-6. PubMed ID: 24703654 [No Abstract] [Full Text] [Related]
73. Palmar herald patch in pityriasis rosea. Polat M; Yildirim Y; Makara A Australas J Dermatol; 2012 Aug; 53(3):e64-5. PubMed ID: 22881477 [TBL] [Abstract][Full Text] [Related]
74. Dermoscopy in General Dermatology: A Practical Overview. Errichetti E; Stinco G Dermatol Ther (Heidelb); 2016 Dec; 6(4):471-507. PubMed ID: 27613297 [TBL] [Abstract][Full Text] [Related]
76. Pityriasis rosea-like Drug Eruption Induced by Imatinib Mesylate (Gleevec™). Cho AY; Kim DH; Im M; Lee Y; Seo YJ; Lee JH Ann Dermatol; 2011 Dec; 23(Suppl 3):S360-3. PubMed ID: 22346278 [TBL] [Abstract][Full Text] [Related]
77. Cytolytic degeneration of keratinocytes adjacent to Langerhans cells in pityriasis rosea (Gibert). Takaki Y; Miyazaki H Acta Derm Venereol; 1976; 56(2):99-103. PubMed ID: 58531 [TBL] [Abstract][Full Text] [Related]
78. Atypical pityriasis rosea. Imamura S; Ozaki M; Oguchi M; Okamoto H; Horiguchi Y Dermatologica; 1985; 171(6):474-7. PubMed ID: 4092804 [TBL] [Abstract][Full Text] [Related]
79. Tongue and cheek: oral lesions in pityriasis rosea. Vidimos AT; Camisa C Cutis; 1992 Oct; 50(4):276-80. PubMed ID: 1424793 [TBL] [Abstract][Full Text] [Related]
80. Low-dose Ultraviolet A1 Phototherapy for Treating Pityriasis Rosea. Lim SH; Kim SM; Oh BH; Ko JH; Lee YW; Choe YB; Ahn KJ Ann Dermatol; 2009 Aug; 21(3):230-6. PubMed ID: 20523795 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]